Hester Biosciences Limited Financial Ratios
HESTERBIO · Healthcare · Current price ₹2,236
P/E ratio
33.1x
P/B ratio
5.4x
ROE
15.4%
ROCE
15.8%
Debt / Equity
0.52
Dividend yield
0.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 33.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 15.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.52 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Hester Biosciences Limited's latest numbers.
Hester Biosciences Limited profitability
Hester Biosciences Limited generates a return on equity of 15.4% and a return on capital employed of 15.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.52 and a P/E of 33.1x, Hester Biosciences Limited is moderately leveraged. Our overall business-quality score for the company is 5.5 / 10.
Understand the ratios
More on Hester Biosciences Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.